Literature DB >> 10501262

Nosocomial infections caused by multiresistant Pseudomonas aeruginosa.

E A Arruda1, I S Marinho, M Boulos, S I Sinto, H H Caiaffa, C M Mendes, C P Oplustil, H Sader, C E Levy, A S Levin.   

Abstract

A case-control study was done to evaluate factors associated with nosocomial infections by multiresistant Pseudomonas aeruginosa (MRPA). Results showed that MRPA was associated with the use of immunosuppressive and antimicrobial drugs. Five typing methods indicated that the MRPA infections were due to multiple strains rather than a single strain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501262     DOI: 10.1086/501683

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  19 in total

1.  Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.

Authors:  F Luzzaro; E Mantengoli; M Perilli; G Lombardi; V Orlandi; A Orsatti; G Amicosante; G M Rossolini; A Toniolo
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.

Authors:  Y H Yau; B Ho; N S Tan; M L Ng; J L Ding
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

3.  Synergistic activities of an efflux pump inhibitor and iron chelators against Pseudomonas aeruginosa growth and biofilm formation.

Authors:  Yang Liu; Liang Yang; Søren Molin
Journal:  Antimicrob Agents Chemother       Date:  2010-06-21       Impact factor: 5.191

4.  Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.

Authors:  Alain Combes; Charles-Edouard Luyt; Jean-Yves Fagon; Michel Wolff; Jean-Louis Trouillet; Jean Chastre
Journal:  Intensive Care Med       Date:  2006-09-07       Impact factor: 17.440

5.  Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.

Authors:  Simone Aranha Nouér; Marcio Nucci; Márcia P de-Oliveira; Flávia Lúcia Piffano Costa Pellegrino; Beatriz Meurer Moreira
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

6.  Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping.

Authors:  S Brisse; D Milatovic; A C Fluit; K Kusters; A Toelstra; J Verhoef; F J Schmitz
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.

Authors:  Thomas P Lodise; Christopher D Miller; Jeffrey Graves; Jon P Furuno; Jessina C McGregor; Ben Lomaestro; Eileen Graffunder; Louise-Anne McNutt
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

Review 8.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

9.  Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients.

Authors:  José A Martínez; Esther Delgado; Sara Martí; Francesc Marco; Jordi Vila; Josep Mensa; Antoni Torres; Carles Codina; Antoni Trilla; Alex Soriano; Aitor Alquezar; Pedro Castro; José M Nicolás
Journal:  Intensive Care Med       Date:  2008-10-21       Impact factor: 17.440

10.  Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil.

Authors:  Flávia Lúcia Piffano Costa Pellegrino; Lúcia Martins Teixeira; Maria da Glória Siqueira Carvalho Md; Simone Aranha Nouér; Márcia Pinto De Oliveira; Jorge Luiz Mello Sampaio; Andrea D'Avila Freitas; Adriana Lucia Pires Ferreira; Efigenia de Lourdes Teixeira Amorim Ed; Lee W Riley; Beatriz Meurer Moreira
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.